Literature DB >> 17016824

Lifetime adult weight gain, central adiposity, and the risk of pre- and postmenopausal breast cancer in the Western New York exposures and breast cancer study.

Daikwon Han1, Jing Nie, Matthew R Bonner, Susan E McCann, Paola Muti, Maurizio Trevisan, Farah A Ramirez-Marrero, Dominica Vito, Jo L Freudenheim.   

Abstract

While there are quite consistent data regarding associations of body weight and postmenopausal breast cancer, there are now accumulating data that would indicate that weight gain in adult life is more predictive of risk than absolute body weight. There is, however, little known about the relative impact of timing of weight gain in adult life as well as other characteristics of the weight and breast cancer association that might provide insight into the mechanism of the observation. We conducted a population-based case control study of breast cancer (1996-2001), the Western New York Exposures and Breast Cancer Study. Included were 1,166 women with primary, histologically confirmed, incident breast cancer and 2,105 controls frequency-matched on age, race and county of residence. Unconditional logistic regression was used to estimate odds ratios and 95% confidence intervals. We found increased risk of breast cancer associated with lifetime adult weight gain among post- but not premenopausal women, and there was a 4% increase in risk for each 5 kg increase in adult weight. Further there was a tendency toward a stronger association for those with higher waist circumference and those with positive estrogen or progesterone status, and who had never used HRT. We also found an association with risk for weight gain since first pregnancy and for weight gain between the time of the first pregnancy and menopause, independent of body mass index and lifetime adult weight gain. Our results suggest that there are time periods of weight gain that have greater impact on risk, and that central body fat, receptor status and hormone replacement therapy may all affect the observed association. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17016824     DOI: 10.1002/ijc.22236

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  28 in total

1.  A case-control study of body mass index and breast cancer risk in white and African-American women.

Authors:  Paula Berstad; Ralph J Coates; Leslie Bernstein; Suzanne G Folger; Kathleen E Malone; Polly A Marchbanks; Linda K Weiss; Jonathan M Liff; Jill A McDonald; Brian L Strom; Michael S Simon; Dennis Deapen; Michael F Press; Ronald T Burkman; Robert Spirtas; Giske Ursin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05-25       Impact factor: 4.254

2.  Genetic variants in COX-2, non-steroidal anti-inflammatory drugs, and breast cancer risk: the Western New York Exposures and Breast Cancer (WEB) Study.

Authors:  Theodore M Brasky; Matthew R Bonner; Kirsten B Moysich; Heather M Ochs-Balcom; Catalin Marian; Christine B Ambrosone; Jing Nie; Meng Hua Tao; Stephen B Edge; Maurizio Trevisan; Peter G Shields; Jo L Freudenheim
Journal:  Breast Cancer Res Treat       Date:  2010-07-30       Impact factor: 4.872

3.  DNA methylation and breast tumor clinicopathological features: The Western New York Exposures and Breast Cancer (WEB) study.

Authors:  Catherine L Callahan; Youjin Wang; Catalin Marian; Daniel Y Weng; Kevin H Eng; Meng-Hua Tao; Christine B Ambrosone; Jing Nie; Maurizio Trevisan; Dominic Smiraglia; Stephen B Edge; Peter G Shields; Jo L Freudenheim
Journal:  Epigenetics       Date:  2016-05-31       Impact factor: 4.528

4.  Height, body mass index (BMI), BMI change, and the risk of estrogen receptor-positive, HER2-positive, and triple-negative breast cancer among women ages 20 to 44 years.

Authors:  Masaaki Kawai; Kathleen E Malone; Mei-Tzu C Tang; Christopher I Li
Journal:  Cancer       Date:  2014-02-05       Impact factor: 6.860

5.  Polycyclic aromatic hydrocarbons and postmenopausal breast cancer: An evaluation of effect measure modification by body mass index and weight change.

Authors:  Nicole Niehoff; Alexandra J White; Lauren E McCullough; Susan E Steck; Jan Beyea; Irina Mordukhovich; Jing Shen; Alfred I Neugut; Kathleen Conway; Regina M Santella; Marilie D Gammon
Journal:  Environ Res       Date:  2016-10-12       Impact factor: 6.498

6.  Body size and breast cancer risk: the Multiethnic Cohort.

Authors:  Kami K White; Song-Yi Park; Laurence N Kolonel; Brian E Henderson; Lynne R Wilkens
Journal:  Int J Cancer       Date:  2012-01-27       Impact factor: 7.396

Review 7.  Pregnancy characteristics and maternal breast cancer risk: a review of the epidemiologic literature.

Authors:  Sarah Nechuta; Nigel Paneth; Ellen M Velie
Journal:  Cancer Causes Control       Date:  2010-03-12       Impact factor: 2.506

8.  Interaction between smoking and obesity and the risk of developing breast cancer among postmenopausal women: the Women's Health Initiative Observational Study.

Authors:  Juhua Luo; Kimberly Horn; Judith K Ockene; Michael S Simon; Marcia L Stefanick; Elisa Tong; Karen L Margolis
Journal:  Am J Epidemiol       Date:  2011-08-29       Impact factor: 4.897

Review 9.  Minireview: Obesity and breast cancer: the estrogen connection.

Authors:  Margot P Cleary; Michael E Grossmann
Journal:  Endocrinology       Date:  2009-04-16       Impact factor: 4.736

10.  A pilot randomized controlled trial of a commercial diet and exercise weight loss program in minority breast cancer survivors.

Authors:  Heather A Greenlee; Katherine D Crew; Jennie M Mata; Paula S McKinley; Andrew G Rundle; Wenfei Zhang; Yuyan Liao; Wei Y Tsai; Dawn L Hershman
Journal:  Obesity (Silver Spring)       Date:  2013-01       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.